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The contingent negative variation (CNV) is a long-latency event-related potential elicited by paired or associated 
stimuli. We recorded contingent negative variation in 50 patients with complex partial and secondarily generalized 
seizures and in 20 neurologically and psychiatrically normal unmedicated controls. 
CNV was recorded from Fz, Cz, and Pz. A 2000 Hz tone was followed after 1.5 s by 1000 microsecond light flash, 
at which a button press was to be executed. Filter band pass was 0.1-20 Hz, analysis time was 10 s and 10 responses 
were replicated. 
Patients with complex partial seizures with and without secondary generalization had lower measurements of 
area under the CNV curve (AUC) than did controls, and CNV amplitude was significantly reduced. Patients with 
interictal behavioural symptoms had significantly smaller AUC and lower amplitude. No significant difference was 
found between depressed and non-depressed seizure patients with respect to AUC, but amplitude was significantly 
lower in depressed patients. Seizure patients with psychosis had significantly lower AUC but did not differ from 
non-psychotic patients in CNV amplitude. No differences were found between seizure patients with and without 
personality disorder with respect to CNV AUC or amplitude. Post-imperative negative variation was significantly 
more common in seizure patients than in controls and among patients with epilepsy, was significantly increased in 
those with inter-ictai behaviour disturbance generally and psychosis particularly. No specific effect of anticonvul- 
sant monotherapy on AUC or amplitude was identified. 
These findings suggest that CNV may differ between partial epilepsy patients and controls, and that inter-ictal 
behaviour disturbance may particularly affect CNV measures. They also agree with previous evidence for a frontal 
lobe generator for the CNV, and a possible role for central dopaminergic pathways in the production of PINV. 
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INTRODUCTION 
The contingent negative variation (CNV) is a 
long-latency event-related potential related to the 
association or contingency between two stimuli’. 
It has been extensively studied in the psychophy- 
siological literature*. Although many studies have 
been undertaken in psychiatric disorders3, rela- 
tively few neurological applications have been 
investigated“. CNV has not been systematically 
applied to date in the evaluation of epilepsy 
patients. 
The CNV may nevertheless be useful in 
assessment of epilepsy and neurobehavioural 
disorders. Recordings in patients who have had 
psychosurgery” and magnetoencephalographical 
evidence6 suggest a frontal lobe origin for at least 
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some CNV components. The CNV has been 
shown to reflect central dopaminergical 
activity”“, and the post-imperative negative varia- 
tion (PINV) may, in particular, reflect the 
influence of dopamine. These associations might 
make the CNV useful in assessment of epilepsy, 
particularly seizures of frontal lobe origin, and in 
the further characterization of inter-ictal neuro- 
psychiatric symptoms and possibly medication 
effects. 
We compared CNV in patients with complex 
partial seizures with and without secondary 
generalization, satisfactorily controlled with anti- 
convulsant monotherapy, with responses re- 
corded in neurologically and psychiatrically intact 
unmedicated controls. 
METHODS 
A group of 50 consecutive patients, approxim- 
ately equally divided between male and female, 
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were selected during outpatient evaluation in the 
Epilepsy Center. They had complex partial 
seizures with and without secondary generaliza- 
tion, diagnosed clinically or by EEG monitoring. 
Eighteen channel sleep-deprived EEGs had 
previously been abnormal, with focal slowing, 
epileptiform activity, or recorded seizures, but 
EEG background was otherwise normal. Comp- 
uted tomographic or magnetic resonance imaging 
tests had been negative with respect to causative 
structural lesions, although volumetric MRI 
measurements were not done. Of the patients, 23 
were taking carbamazepine monotherapy, 17 
were on phenytoin alone and 10 patients were 
treated only with valproate. All had therapeutic 
anticonvulsant levels without toxic symptoms. 
The 50 patients were healthy except for 
epilepsy, but 30 had documented symptoms 
involving inter-ictal behaviour or personality, for 
which they had received psychiatric treatment, 
sought psychological counselling, or become 
involved in support groups of the Epilepsy 
Association of Central Ohio. Sixteen patients had 
previously received diagnosis of a depressive 
disorder or reaction, five patients had been 
psychiatrically hospitalized for psychosis, and 25 
patients had had behavioural or personality 
disturbance other than psychosis. Psychiatric or 
psychological evaluation had yielded diagnoses of 
personality disorder in nine patients. Seizure 
patients were compared to 20 control subjects, 
aged 20-40 years, equally divided between males 
and females, and taking no medications at the 
time of study. 
The CNV was recorded from silver-silver 
chloride electrodes placed at the Fz, Cz, and Pz 
positions of the International lo:20 electrode 
placement. Responses were recorded from Fz 
with linked ear reference, the Cz and Pz positions 
serving to assist in peak identification. Additional 
electrodes were placed at the outer canthi of both 
eyes, and ocular artefact was excluded by bipolar 
recording. A 2000 Hz tone, delivered at 76 dB SL 
binaurally through shielded headphones, was 
followed after 1.5 s by a 100 ps light flash, at 
which the patient or subject had been instructed 
to press a button. The amplitude and area under 
the curve (AUC) of the frontal CNV were 
measured in patients and controls, as was the 
occurrence of post-imperative negative variation 
(PINV). 
RESULTS 
CNV recordings in control subjects, seizure 
patients without inter-ictal behavioural symp- 
toms, and epileptics with inter-ictal psychosis, 
personality disorder, or depression, are ex- 
emplified in the Figs. l-3. AUC and amplitude 
measurements and frequency of PINV in each of 
the groups are summarized in Table 1. 
Patients with complex partial seizures with and 
without secondary generalization had sig- 
nificantly smaller AUC than did controls. They 
also had a significant reduction in CNV ampli- 
tude. Patients with inter-ictal behaviour symp- 
toms had significantly smaller AUC and lower 
amplitude. Depressed individuals did not differ 
from non-depressed patients with regard to AUC, 
but had significantly smaller CNV amplitude. 
Conversely, patients with seizures and psychosis 
had significantly larger AUC than patients 
without psychosis, but amplitudes were not 
significantly different. No significant differences 
in AUC or amplitude were found in complex 
partial seizure patients felt to have personality 
disorders and seizure patients without personahty 
disorder. PINV was significantly more common in 
the seizure patients than in the controls, and 
patients groups with and without inter-ictal 
behaviour symptoms, and with and without 
psychosis, differed significantly, although no 
significant differences were found between de- 
pressed and non-depressed patients and patients 
with and without personality disorder. 
No differences were found evident between 
therapeutic levels of carbamazepine, phenytoin, 
and valproate on monotherapy CNV amplitude 
or AUC. The depressed and psychotic patients 
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Fig. 1: Contingent negative variation recorded as described 
in the Methods section in a control subject. A reproducible 
negative potential develops between the warning (‘Ll’) and 
imperatrice (‘L2’) stimuli, followed by a brief period of 
negativity and then return of the EEG to baseline. The fourth 
channel represents eiectro-oculogram. recorded between 
linked electrodes at the outer canthi. 
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Fig. 2: CNV in a patient with complex partial seizures 
unattended by inter-ictal cognitive or behavioural 
symptoms. The response has similar morphology but 
reduced amplitude. 
were not taking antidepressant or antipsychotic 
drugs at the time of their evaluation, although 
some had been on medications for these problems 
within a week before the study. No other 
prescription medications were reported, but the 
use of over-the-counter medications or other 
substances was not addressed. 
DISCUSSION 
The CNV is attenuated by psychosurgical proce- 
dures on the frontal lobes and may therefore 
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Fig. 3: CNV in a patient with poorly controlled complex 
partial and secondarily generalized seizures attended by 
personality disorder. The response is attenuated in 
amplitude and followed at ‘L3’ by a prolonged negative 
potential (post-imperative negative variation). 
have, at least in part, a frontal generato?. The 
early component of the magnetic contingent 
negative variation (CMV) has shown to arise in 
the occipital region, while the later component 
has a frontal generator6. CNV has been shown to 
be closely modulated by noradrenergic’ and 
dopaminergic” systems, and some application has 
been shown in some neurological disorders of 
central catecholamine metabolism, such as 
migraine’, Parkinson’s disease”, and Tourette’s 
syndrome’ ‘. The response has been less well 
studied in epilepsy, with attenuation of frontal 
CNV in centrenecephalic epilepsy and also during 
epileptiform discharges of temporal lobe origin12. 
These earlier studies predated present epilepsy 
classification, and did not relate CNV measures to 
antiepileptic drug treatment or any specific 
clinical features. 
Our findings suggest that epilepsy patients 
generally had CNV attenuation compared to 
normal controls. This may suggest some 
involvement by temporal lobe or limbic structures 
in CNV generation, in addition to the frontal 
generators previously suggested, or may reflect 
the prominence of frontal lobe epilepsy in a 
tertiary referral population of partial seizure 
patients. CNV attenuation in patients with 
inter-ictal disturbance of behaviour or personality 
could reflect the role that frontal lobe dysfunction 
plays in such symptoms, and might also make the 
CNV useful in the evaluation of inter-ictal 
behaviour in epilepsy. 
We found no anticonvulsant-specific CNV 
effects, although amplitude reduction has been 
shown with carbamazepinei3 and clonazepam’4 in 
previous studies. This discrepancy may reflect the 
fact that earlier studies of drug effect on CNV 
utilized acute administration of high doses to 
normal volunteers, while we measured CNV in 
chronically medicated individuals and did not 
otherwise assess anticonvulsant status except to 
exclude patients with toxic anticonvulsant levels. 
Patients with inter-ictal behaviour symptoms 
involving psychosis had CNV enhancement as 
measured by AUC, although amplitudes did not 
differ significantly from controls. Patients with 
psychosis were also more likely to have PINV, 
which has been correlated with psychotic illness 
and possibly with central dopaminergic state2, 
and has been shown to arise during treatment of 
Parkinson’s disease” and to be more frequent in 
patients with Tourette’s syndrome, which is a 
disorder of dopamine excess”. This suggests that 
CNV enhancement or the development of PINV 
might indicate susceptibility to inter-ictal 
behavioural symptoms generally and psychosis 
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Table 1: CNV measurements in seizure patients and controls 
n Area under curve Amplitude PINV 
(uV2 + sd) (uV + sd) 
Complex partial seizures 50 5.4 + 3.14 5.98 + 3.44” Ila 
Control 20 13.8+ 11.5 2.81 + 3.44 2 
Inter-ictal behavioural symptoms 30 4.23 + 3.13” 4.68 + 3.10” 1 1” 
No inter-ictal behavioural symptoms 20 7.15 + 2.16 8.01 + 3.05 2 
Depressed 16 4.91 + 4.45 3.07 + 0.21” 5 
Non-depressed 34 5.63 + 2.80 7.39 + 3.70 5 
Psychotic 5 9.17 + 5.29h 7.48 + 6.29 3 
Non-psychotic 25 3.24 + 1.13 4.11 + 1.78 2 
Personality disorder 9 2.86 + 0.88 4.68 + 2.35 3 
No personality disorder 21 5.92 + 4.48 4.11 + 3.39 2 
“P<O.OOl. 
h P < 0.05. 
particularly, and may be of value in the periodic 
assessment of refractory seizure patients. 
Our patients with epilepsy and depression had 
no difference in CNV AUC, but reduced ampli- 
tude compared to controls and non-depressed 
patients. Such amplitude attenuation has been 
described in various depressive disorders, along 
with amplitude increase during treatment with 
antidepressants which augment central catechol- 
amine levels*. CNV amplitude reduction may 
therefore be relevant to development or progres- 
sion of depressive symptoms in seizure patients, 
and might be a measure of antidepressant efficacy 
of anticonvulsant or other medication regimens. 
CNV can easily be recorded with evoked 
potential instrumentation or in some cases on 
EEG instruments. Monitoring of patient state 
and ocular artefact is mandatory, as are means of 
delivering two associated or contingent stimuli, 
preferably with a motor task afterward which 
increases CNV amplitude. The utility of CNV 
recording in epilepsy evaluation may be clarified 
by prospective studies comparing patients with 
and without secondarily generalized seizures, and 
investigating the influence on CNV of the 
presumed sites of origin of partial seizures. 
Comparison of antiepileptic drug monotherapy 
and polypharmacy and correlation of CNV 
amplitude and latency with anticonvulsant level is 
also appropriate. More specific correlations of 
CNV measures with psychometric test variables 
and quantitative measures of psychiatric sympto- 
matology would also be appropriate, and may 
indicate the extent to which CNV changes in 
these patients are determined by epilepsy on the 
one hand or neuropsychiatric symptoms on the 
other. 
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